Table 1.
Model parameters | Contribution | No. of parameters | Prior | Posterior | |||||
---|---|---|---|---|---|---|---|---|---|
Distribution | Mean | SD | Source | Median | CR | ||||
Study population | Age group size | Fixed | 6 age groups | – | – | – | KHDSS [4] | – | – |
Contact patterns | Fixed | 6 × 6 age groups | – | – | – | KHDSS [5] | – | – | |
Carriage prevalence | Outcome | 2 types × 6 age groups | – | – | – | KHDSS [11] | – | – | |
IPD | Outcome | 2 types × 6 age groups | – | – | – | KHDSS [12] | – | – | |
Observed vaccine coverage | Fixed | 27,040 (weekly age and time) | – | – | – | KHDSS [4] | – | – | |
Transmission dynamics | Clearance rates | Fixed | 2 types × 4 age groups | KHDSS [15] | |||||
VE carriage (toddlers) | Fitted - prior | 1 | Normal | 0.36 | 0.15 | KHDSS [11] | 0.56 | 0.41–0.72 | |
VE IPD (infants) | Fitted - prior | 1 | Normal | 0.80 | 0.1 | [22] | 0.86 | 0.67–0.99 | |
Duration of protection (toddlers) | Fitted - prior | 1 | Normal | 6 years | 3 | [23, 24] | 5.50 | 2.05–11.01 | |
Relative level of infant protection | Fitted - prior | 1 | Normal | 1 | 0.1 | Assumption | 0.97 | 0.78–1.17 | |
Competition parameter | Fitted - prior | 1 | Log-normal | 0.15 | 0.15 | [17, 18] | 0.19 | 0.07–0.44 | |
Susceptibility to infection | Fitted - no prior | 2 types × 4 age groups | |||||||
Invasiveness | Fitted - no prior | 2 types × 4 age groups |
CR Credible range, VE Vaccine efficacy